Click for best price
Nephrology Drugs Market Size, Share 2023
Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.
This report aims to provide a comprehensive presentation of the global market for Nephrology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nephrology Drugs. This report contains market size and forecasts of Nephrology Drugs in global, including the following market information:
Global Nephrology Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Nephrology Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
ACE Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nephrology Drugs include AstraZeneca, Pfizer, Amgen, FibroGen, GlaxoSmithkline, AbbVie, Akebia Therapeutics, Teva Pharmaceutical Industries and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nephrology Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nephrology Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Nephrology Drugs Market Segment Percentages, by Type, 2022 (%)
ACE Inhibitors
Calcium Channel Blocker
Beta Blockers
Diuretics
Others
Global Nephrology Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Nephrology Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Nephrology Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Nephrology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nephrology Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nephrology Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Pfizer
Amgen
FibroGen
GlaxoSmithkline
AbbVie
Akebia Therapeutics
Teva Pharmaceutical Industries
Johnson & Johnson
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nephrology Drugs, market overview.
Chapter 2: Global Nephrology Drugs market size in revenue.
Chapter 3: Detailed analysis of Nephrology Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nephrology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nephrology Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nephrology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nephrology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nephrology Drugs Overall Market Size
2.1 Global Nephrology Drugs Market Size: 2022 VS 2032
2.2 Global Nephrology Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nephrology Drugs Players in Global Market
3.2 Top Global Nephrology Drugs Companies Ranked by Revenue
3.3 Global Nephrology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Nephrology Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nephrology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nephrology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Nephrology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Nephrology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nephrology Drugs Market Size Markets, 2022 & 2032
4.1.2 ACE Inhibitors
4.1.3 Calcium Channel Blocker
4.1.4 Beta Blockers
4.1.5 Diuretics
4.1.6 Others
4.2 By Type - Global Nephrology Drugs Revenue & Forecasts
4.2.1 By Type - Global Nephrology Drugs Revenue, 2018-2023
4.2.2 By Type - Global Nephrology Drugs Revenue, 2024-2032
4.2.3 By Type - Global Nephrology Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nephrology Drugs Market Size, 2022 & 2032
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Nephrology Drugs Revenue & Forecasts
5.2.1 By Application - Global Nephrology Drugs Revenue, 2018-2023
5.2.2 By Application - Global Nephrology Drugs Revenue, 2024-2032
5.2.3 By Application - Global Nephrology Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Nephrology Drugs Market Size, 2022 & 2032
6.2 By Region - Global Nephrology Drugs Revenue & Forecasts
6.2.1 By Region - Global Nephrology Drugs Revenue, 2018-2023
6.2.2 By Region - Global Nephrology Drugs Revenue, 2024-2032
6.2.3 By Region - Global Nephrology Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Nephrology Drugs Revenue, 2018-2032
6.3.2 US Nephrology Drugs Market Size, 2018-2032
6.3.3 Canada Nephrology Drugs Market Size, 2018-2032
6.3.4 Mexico Nephrology Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Nephrology Drugs Revenue, 2018-2032
6.4.2 Germany Nephrology Drugs Market Size, 2018-2032
6.4.3 France Nephrology Drugs Market Size, 2018-2032
6.4.4 U.K. Nephrology Drugs Market Size, 2018-2032
6.4.5 Italy Nephrology Drugs Market Size, 2018-2032
6.4.6 Russia Nephrology Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Nephrology Drugs Market Size, 2018-2032
6.4.8 Benelux Nephrology Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Nephrology Drugs Revenue, 2018-2032
6.5.2 China Nephrology Drugs Market Size, 2018-2032
6.5.3 Japan Nephrology Drugs Market Size, 2018-2032
6.5.4 South Korea Nephrology Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Nephrology Drugs Market Size, 2018-2032
6.5.6 India Nephrology Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Nephrology Drugs Revenue, 2018-2032
6.6.2 Brazil Nephrology Drugs Market Size, 2018-2032
6.6.3 Argentina Nephrology Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nephrology Drugs Revenue, 2018-2032
6.7.2 Turkey Nephrology Drugs Market Size, 2018-2032
6.7.3 Israel Nephrology Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Nephrology Drugs Market Size, 2018-2032
6.7.5 UAE Nephrology Drugs Market Size, 2018-2032
7 Nephrology Drugs Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Nephrology Drugs Major Product Offerings
7.1.4 AstraZeneca Nephrology Drugs Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Nephrology Drugs Major Product Offerings
7.2.4 Pfizer Nephrology Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Nephrology Drugs Major Product Offerings
7.3.4 Amgen Nephrology Drugs Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 FibroGen
7.4.1 FibroGen Company Summary
7.4.2 FibroGen Business Overview
7.4.3 FibroGen Nephrology Drugs Major Product Offerings
7.4.4 FibroGen Nephrology Drugs Revenue in Global Market (2018-2023)
7.4.5 FibroGen Key News & Latest Developments
7.5 GlaxoSmithkline
7.5.1 GlaxoSmithkline Company Summary
7.5.2 GlaxoSmithkline Business Overview
7.5.3 GlaxoSmithkline Nephrology Drugs Major Product Offerings
7.5.4 GlaxoSmithkline Nephrology Drugs Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithkline Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Nephrology Drugs Major Product Offerings
7.6.4 AbbVie Nephrology Drugs Revenue in Global Market (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Akebia Therapeutics
7.7.1 Akebia Therapeutics Company Summary
7.7.2 Akebia Therapeutics Business Overview
7.7.3 Akebia Therapeutics Nephrology Drugs Major Product Offerings
7.7.4 Akebia Therapeutics Nephrology Drugs Revenue in Global Market (2018-2023)
7.7.5 Akebia Therapeutics Key News & Latest Developments
7.8 Teva Pharmaceutical Industries
7.8.1 Teva Pharmaceutical Industries Company Summary
7.8.2 Teva Pharmaceutical Industries Business Overview
7.8.3 Teva Pharmaceutical Industries Nephrology Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Nephrology Drugs Revenue in Global Market (2018-2023)
7.8.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Nephrology Drugs Major Product Offerings
7.9.4 Johnson & Johnson Nephrology Drugs Revenue in Global Market (2018-2023)
7.9.5 Johnson & Johnson Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Nephrology Drugs Major Product Offerings
7.10.4 Roche Nephrology Drugs Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nephrology Drugs Market Opportunities & Trends in Global Market
Table 2. Nephrology Drugs Market Drivers in Global Market
Table 3. Nephrology Drugs Market Restraints in Global Market
Table 4. Key Players of Nephrology Drugs in Global Market
Table 5. Top Nephrology Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nephrology Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nephrology Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nephrology Drugs Product Type
Table 9. List of Global Tier 1 Nephrology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nephrology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nephrology Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Nephrology Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nephrology Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Nephrology Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Nephrology Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nephrology Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Nephrology Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Nephrology Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nephrology Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Nephrology Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nephrology Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Nephrology Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nephrology Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Nephrology Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nephrology Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Nephrology Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nephrology Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Nephrology Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nephrology Drugs Revenue, (US$, Mn), 2024-2032
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Nephrology Drugs Product Offerings
Table 32. AstraZeneca Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Nephrology Drugs Product Offerings
Table 36. Pfizer Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen Nephrology Drugs Product Offerings
Table 40. Amgen Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. FibroGen Company Summary
Table 43. FibroGen Nephrology Drugs Product Offerings
Table 44. FibroGen Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. FibroGen Key News & Latest Developments
Table 46. GlaxoSmithkline Company Summary
Table 47. GlaxoSmithkline Nephrology Drugs Product Offerings
Table 48. GlaxoSmithkline Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithkline Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Nephrology Drugs Product Offerings
Table 52. AbbVie Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. AbbVie Key News & Latest Developments
Table 54. Akebia Therapeutics Company Summary
Table 55. Akebia Therapeutics Nephrology Drugs Product Offerings
Table 56. Akebia Therapeutics Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Akebia Therapeutics Key News & Latest Developments
Table 58. Teva Pharmaceutical Industries Company Summary
Table 59. Teva Pharmaceutical Industries Nephrology Drugs Product Offerings
Table 60. Teva Pharmaceutical Industries Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Pharmaceutical Industries Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Nephrology Drugs Product Offerings
Table 64. Johnson & Johnson Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Nephrology Drugs Product Offerings
Table 68. Roche Nephrology Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Key News & Latest Developments
List of Figures
Figure 1. Nephrology Drugs Segment by Type in 2022
Figure 2. Nephrology Drugs Segment by Application in 2022
Figure 3. Global Nephrology Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nephrology Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Nephrology Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nephrology Drugs Revenue in 2022
Figure 8. By Type - Global Nephrology Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Nephrology Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Nephrology Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Nephrology Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Nephrology Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Nephrology Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Nephrology Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Nephrology Drugs Revenue Market Share, 2018-2032
Figure 16. US Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Nephrology Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Nephrology Drugs Revenue Market Share, 2018-2032
Figure 28. China Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Nephrology Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Nephrology Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Nephrology Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. AstraZeneca Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. FibroGen Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithkline Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AbbVie Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Akebia Therapeutics Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Pharmaceutical Industries Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Johnson & Johnson Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
